Pharmicell Major Shareholder Stake Edges Up to 9.39% on Executive Kim Soo-chan's Open Market Purchase

Pharmicell's major shareholder group ownership slightly increased to 9.39% as of June 19, 2026, from 9.38% previously.
The change stems from executive Kim Soo-chan's open market purchase of 668 common shares, raising his total holdings to 4,414 shares.
Given the negligible scale of 0.001% relative to 60,004,014 total outstanding shares, this filing indicates no dilution or capital allocation impact.
[AI Summary]This routine insider buying reflects management confidence but does not alter Pharmicell's capital structure or growth strategy. Shareholders may view it as mildly positive, but the financial impact is minimal.